Real World Evidence of the Effectiveness of ABT-450/r - Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Ireland
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 15 Sep 2017
At a glance
- Drugs Dasabuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms REACH
- Sponsors AbbVie
- 11 Sep 2017 Planned number of patients changed from 100 to 150.
- 11 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 13 Feb 2017 Planned number of patients changed from 150 to 100.